Heptoses are found in the surface polysaccharides of most bacteria, contributing to structures that are essential for virulence and antibiotic resistance. Consequently, the biosynthetic enzymes for these sugars are attractive targets for novel antibiotics. The best characterized biosynthetic enzyme is GmhA, which catalyzes the conversion of sedoheptulose-7-phosphate into D-glycero-D-manno-heptopyranose-7-phosphate, the first step in the biosynthesis of heptose. Here, the structure of GmhA from Burkholderia pseudomallei is reported. This enzyme contains a zinc ion at the heart of its active site: this ion stabilizes the active, closed form of the enzyme, and presents co-ordinating side chains as a potential acid and base to drive catalysis. A complex with the product demonstrates that the enzyme retains activity in the crystal, and so suggests that the closed conformation is catalytically relevant, and is an excellent target for the development of therapeutics. A revised mechanism for the action of GmhA is postulated on the basis of this structure and the activity of B. pseudomallei GmhA mutants.
infection; 15, 16 acapsular mutants are strongly attenuated; 14, 17, 18 and the biosynthetic genes are absent in related, less pathogenic species. 14 In addition to providing a general defence against immune challenge, B.
pseudomallei CPS-I actively inhibits complement C3b, providing a defense against innate immunity.
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CPS-I is thus an attractive target for vaccine and small molecule inhibitor development.
The CPS-I structure is extremely simple, comprising a linear polymer of 2-O-acetyl-6-deoxy--D-mannoheptopyranose (2O6dDHep; Figure 1b , c). 14, 20 Heptoses are rarely found in higher eukaryotes, but are common in bacterial polysaccharides. In E. coli LPS, L-glycero--D-manno-heptopyranose (DHep), forms part of the "inner core", which is essential for virulence. In other pathogens, heptoses are used in a variety of polysaccharides: 6-deoxy-D-manno-heptopyranose (6dDHep) forms part of the LPS O-antigen in both
Yersinia pseudotuberculosis 21 and Campylobacter jejuni. 22 Heptose biosynthesis follows one of two divergent pathways in different bacteria, providing different nucleotide-linked sugars according to the needs of the bacterium. 10, 23 However, the initial stages of biosynthesis of DHep from the pentose phosphate pathway intermediate sedoheptulose-7-phosphate (S7P) are common to both pathways. The wide distribution of these enzymes, their essential nature for virulence, and the lack of equivalents in higher eukaryotes make such enzymes excellent targets for the development of novel, broad spectrum antibiotics. 24 A route to the biosynthesis of 2O6dDHep in B. pseudomallei has been proposed ( Figure 1d ; Cuccui et al., manuscript in preparation). A key enzyme in this biosynthetic pathway is GmhA: this is the first enzyme in the pathway, and converts sedoheptulose-7-phosphate into D-glycero-D-manno-heptopyranose-7-
phosphate (M7P). The structures of GmhA from Escherichia coli, Pseudomonas aeruginosa, C. jejuni and
Vibrio cholerae have recently been determined (Table 1) . 25, 26 These structures suggested that GmhA adopts two significant conformations, representing substrate and product binding conformers; and a plausible mechanism was proposed, consistent with all the crystallographic and mutational data and known mechanisms of homologous enzymes. However, whilst the proposed mechanism is a first step towards developing new interventions based on GmhA, some key details were not revealed. It is not clear which conformation is relevant to catalysis, or whether catalysis occurs during a transition between conformations; and no role is apparent for several residues that are in environments often associated with a catalytic role (Figure 2 ). 27 The B. pseudomallei GmhA ortholog retains all of the key conserved amino acids seen in GmhA from these species, whilst having a slightly lower sequence identity than other extant structures (39 % identity to E. coli ortholog; others show > 40 % identity). It therefore represents an attractive target for ascertaining the role of these amino acids whose role is unaccounted for, and the two conformations, in
GmhA activity. Furthermore, it should highlight whether GmhA might similarly represent a good target for antibiotic development against B. pseudomallei. I therefore determined the structure of GmhA from this organism. Surprisingly, the solved structure contains a metal ion in the core of the active site: careful investigation demonstrated that this metal ion is zinc, and suggests that it contributes towards the full activity of the enzyme. The side chains required for binding of this ion are completely conserved across a wide range of bacterial species, suggesting that zinc binding may be common to some other bacterial GmhA enzymes. The solved structure indicates that the "closed" conformation of GmhA is likely to be the catalytically relevant one, and that the previously proposed mechanism for GmhA is unlikely to be correct. The structure suggests an alternative mechanism for GmhA, consistent with all previously published data. This work reveals a novel metal binding site, unprecedented in the SIS enzyme class, and highlights a conformation that should represent an excellent target for the development of effective broad spectrum inhibitors of GmhA.
RESULTS

Structural analysis of His-tagged B. pseudomallei GmhA reveals a novel cation binding site
Crystals of 6-His tagged GmhA grew in space group P1 (Crystal 1; Table 2 ), and the structure was solved by molecular replacement to GmhA from C. jejuni (PDB ID: 1TK9). 25 Eight GmhA protomers were observed in the asymmetric unit: these appeared to form into two tetramers. This is consistent with the previously observed structures of GmhA from E. coli, P. aeruginosa, V. cholerae, and C. jejuni; 25, 26 and with the behavior of the protein in size exclusion chromatography, where it eluted with a Stoke's radius consistent with a tetramer (data not shown). The final model was refined to R and R free values of 18.9 and 24.5 % respectively (Table 2) .
Previously solved structures of GmhA from other organisms have suggested that GmhA crystallizes in one of two conformers, corresponding to substrate and product bound forms ( Table 1) . Comparison of GmhA from B. pseudomallei with these structures showed that this enzyme strongly resembles the "closed" structure, observed in two of the extant GmhA structures, including the one known product bound structure (Figure 3a) . Moreover, the active site of the B. pseudomallei structure shows a clear evidence for an ion. There is an atom present that has electron density consistent with a first row transition metal, which is tetrahedrally co-ordinated (Figure 3b , c). The atom was therefore modelled as zinc, which proved to be an excellent fit to the electron density.
Crystallization of untagged GmhA and determination of metal binding
Since this crystal suggested that GmhA is a metalloenzyme, but did not unambiguously identify the native metal, protein with the His-tag removed was crystallized. The initial crystal form had some crystal contacts involving the TEV cleavage site, so removing this was expected to alter the crystal form.
Untagged GmhA crystallized readily in a range of conditions: all of these crystals were in the space group P2 1 2 1 2 1 , with similar cell dimensions. To determine the identity of the metal in the active site, an extended X-ray absorption fine structure (EXAFS) scan was performed on crystal 2, following collection of a high resolution dataset to 1.62 Å. The emission peaks from this scan were unambiguously characteristic for zinc. Following this, a standard fluorescence scan at the zinc anomalous peak wavelength was performed on crystal 3. This showed a clear anomalous peak (Figure 4a ). Data were collected for anomalous phasing for crystal 3, and these data were sufficient to locate the zinc atoms (Figure 4b ), determine initial phases, and build an initial model for GmhA. This initial model was then refined against the data from crystal 2.
This model was refined to R and R free values of 14.6 and 17.9 % respectively ( Table 2) .
Identification of ligands in the crystal structure
The overall architecture of the structure in this crystal form is strikingly similar to that of the tagged protein (not shown). The structures of crystal 1 and crystal 2 show a main chain RMSD of 0.47 Å. Crystal 2 clearly showed a molecule of the product in each active site (Figure 5a ). The location of the product molecule strong resembles that observed for the product bound form of P. aeruginosa GmhA, with very similar interactions with side chains (Figure 6 ).
GmhA mutants confirm that predicted active site residues are required for full activity
As these structural data all suggested that the GmhA from B. pseudomallei is a metalloenzyme, a range of mutants were designed to test whether the enzyme has similar activity to the E. coli enzyme, 26 and to provide evidence in support of zinc binding. Consequently, the mutations H64Q, E68Q, and Q175E mutants were made in residues ligating the zinc ( Figure 5b ); D98N and T124A mutants in ligand binding residues; and D61A, in a residue drawing protons away from H64 ( Figure 5c ). With the exception of the D61A, which was not tested, these mutations all had displayed reduced or no activity in E. coli. The kinetic parameters for the wild-type enzyme and these mutants (Table 3 ) demonstrate that GmhA from B.
pseudomallei shows a similar activity to the E. coli enzyme. The E68Q, D98N, T124A and Q175E mutants are all inactive, whilst H64Q and D61A mutants retain some activity. This mirrors the behavior of E. coli GmhA, where equivalent mutations showed similar reductions in activity ( Table 3) . Addition of chelating agents (e.g. EDTA) did not significantly affect the rate of the reaction (not shown).
DISCUSSION
B. pseudomallei GmhA is a metalloenzyme
The two structures of GmhA from B. pseudomallei presented here clearly demonstrate that the enzyme is a metalloenzyme, as both structures show a metal at the heart of the active site ( Figures 3 and 5 ). The most convincing proof for this is that the structure could be solved from the anomalous signal of the four zinc atoms located alone ( Figure 4b ). It is likely that the observed zinc is natively bound to the active site, and has been retained from the cell: no zinc was added to any of the purification or crystallization buffers used. Zinc is a common enzyme cofactor, with over 10 % of the well characterized enzyme mechanisms in the MACiE database 28 including a zinc ion.
Comparison of the B. pseudomallei structure with those from other species demonstrates that this enzyme strongly favours the "closed" conformation. 26 This conformation is observed in all three tetramers in the two crystal forms: the conformation is likely to be driven by the metal binding, as a similar constellation of the metal binding side chains is observed in the two structures that also adopt this conformation ( Figure   7 ). As the presence of the metal is clearly important for activity in the B. pseudomallei enzyme, it is unlikely to be able to access the "open" conformation at all, as this would imply loss of the bound metal.
The metal appears to be tightly bound, as zinc binding persisted despite prolonged exposure to imidazole in purification, and several chelating agents failed to reduce the rate of the reaction.
Implications for other orthologs
The structure of GmhA from B. pseudomallei strongly suggests that the "closed" conformation, observed also in structures of P. aeruginosa and V. cholerae GmhA, 25, 26 is most likely to be the catalytically relevant conformation. The structure of the untagged protein presented here shows the product of GmhA, D-glycero--D-manno-heptopyranose-7-phosphate: this indicates that the enzyme is capable of turning over the substrate whilst in the "closed" conformation. Furthermore, crystal 2 was harvested five minutes after soaking with sedoheptulose-7-phosphate, consistent with a rapid turnover in the crystal. These observations suggest that the "closed" conformation is sufficient for substrate binding, and for all of the catalytic steps required to form the product in this enzyme. The "closed" conformation maintains a largely solvent exposed active site, so rapid ingress and egress of substrate and product should be possible. Given the high level of sequence identity between GmhA orthologs (Figure 2 ), this is likely to be the case for
GmhA from all species. The open conformation appears to be suitable for substrate binding, 26 and may be used by some orthologs as a means of facilitating more rapid product release. The relative propensity of different orthologs to access this state may reflect differences in evolved turnover rate; B. pseudomallei represents an extreme, but perhaps not unique, case where the enzyme is locked into the "closed"
conformation. Indeed, all of the previously determined structures used protein that had been purified in the presence of reducing agents, chelating agents, or both, and so it is possible that zinc may have been leached from some of these proteins prior to crystallization. These observations will be extremely important for efforts to rationally design inhibitors against GmhA: the "closed", catalytic, conformation, of the enzyme offers an excellent target for obtaining a strong inhibitor that will mimic the substrate, product or transition state.
Implications for the mechanism of GmhA
Taylor et al. 26 proposed a mechanism for the action of GmhA involving an enediol-switch, with E68 and H183 (their E. coli equivalents) acting as an acid and base respectively to promote isomerization of GmhA ( Figure 8a ). Based on the structures presented here, this mechanism appears unlikely for B.
pseudomallei GmhA, as H183 is buried by the zinc ion in the active site. In contrast, E68 and Q175 bind to the zinc in a manner that strikingly presents these side chains as a potential acid and base (Figure 5d ).
Mutation of either of these residues to the conjugate amide or acid is sufficient to reduce the enzyme rate at least 80 fold: as these mutations would not be expected to prevent zinc binding, this implies that the zinc ion serves principally to orientate these side chains. I therefore propose an amended mechanism, with E68 and Q175 acting as the base and acid respectively to promote this reaction (Figure 8b ). Such a mechanism is consistent with the presence of zinc in the active site of some GmhA orthologs, as zinc ions in other enzymes commonly act to increase the acidity or nucleophilicity of co-ordinating side chains; and the co-ordination of the acid and base in a enediol switch mechanism by zinc has been previously described. 29 The presence of a zinc ion in the active site, and the proposed mechanism, are also consistent with mutant data produced by Taylor et al. 26 and in this work: the most crucial side chains for enzyme activity appear to be E68, H183 and Q175. Mutation of H183 would be expected to have significant consequences for zinc binding in this structure (as it is the most buried zinc ligand), and in both the non-metal bound structures, where a hydrogen bond between H183 and H64 stabilizes the "closed" conformation ( Figure   7 ). Furthermore, the D61A mutant, which should reduce the affinity of H64 for the zinc, shows a considerably reduced activity, whilst H64Q, which should still be capable of providing a ligand to zinc,
shows only a moderate loss in activity (Table 3 ). These observations explain the roles of the conserved residues of D61, H64, E68, Q175, E176, H178 and H183 across bacterial species (Figure 2 ): four of these residues are required to co-ordinate the zinc ion (H64, E68, Q175 and H183), whilst D61 and H178 position and remove electrons from H64 (Figure 5c ), and E176 performs a similar role with H183.
Taylor et al. 26 proposed that cyclization of the heptose following isomerization would occur outside the enzyme. However, in crystal 2, which was soaked for 5 minutes with S7P, the cyclized product is unambiguously observed in all four active sites. This rapid turnover to the cyclized sugar, and the apparent preference for binding this form in the active site argue that GmhA also catalyzes cyclization.
Based on the structures presented here, and on the structure of the complex of P. aeruginosa GmhA with M7P, I propose that D98 acts as a proton shuffle, providing both acid and base functions, to promote the cyclization of the sugar (Figure 8c ). The crystal structures show that O1 of M7P is located suggestively close to the main chain amide of R72 ( Figure 9 ): it is likely that, in the linear form, O1 will form a hydrogen bond with this amide. This interaction drives the conformation of the sugar such that the -anomer of M7P will be preferred in the product. This is in agreement with the proposed pathway for the biosynthesis of the B. pseudomallei capsule, and suggests that anomer selection is made by GmhA in its catalytic steps, rather than by selection from a racemate by a later enzyme.
Conclusions and future prospects
The data presented in this paper suggest a novel metal binding site in GmhA, a key enzyme for the production of heptoses in bacteria. The discovery of this metal binding site has significant implications for the mechanism of the enzyme: the revised mechanism explains the striking conservation of many side chains, including those quite distant from the catalytic centre, throughout the bacterial kingdom; and the structure clearly shows two side chains poised to act as a catalytic acid and base for the reaction. This work suggests that efforts to design inhibitors of GmhA as broad-spectrum antibiotics might be focused on the "closed" conformation, and should take account of the possibility of zinc binding across a range of species. The development of such specific inhibitors will provide important details as to the precise mechanism of the enzyme.
MATERIALS AND METHODS
Preparation of GmhA, WcbL and WcbN
Full length sedoheptulose-7-phosphate isomerase (GmhA; Figure 1 approximately 50 mg of nickel affinity purified protein was incubated at 4°C for 36 hours with 700 g of TEV protease (S219V mutant, purified using methods available at www.mcl1.ncifcrf.gov/waugh_tech/protocols/pur_histev.pdf). The sample was then purified by sizeexclusion chromatography as described above, and extensively loaded over nickel-agarose to remove residual undigested GmhA and TEV.
GmhA Mutagenesis
Site directed mutants of GmhA were generated using the QuikChange II XL mutagenesis kit (Agilent).
Mutations were verified by DNA sequence analysis (MWG, London).
Structure Determination of GmhA
All crystals were grown using the microbatch method, and were prepared using an Oryx6 crystallization robot (Douglas Instruments). Tagged B. pseudomallei GmhA at 10 mg/mL was mixed with an equal volume of crystallization solutions (see Table 4 for details of crystallization and soaking conditions), and grown at 20°C. Prior to flash-freezing in liquid nitrogen, crystals were soaked for 30-60 seconds in a cryoprotectant solution. Tag-removed GmhA at 10 mg/mL was mixed with an equal volume of crystallization solutions, and crystals were grown at 4ºC. Prior to flash freezing, crystals were soaked in cryoprotectant solutions containing proposed substrates (Table 4) minutes. All substrate was converted to product in both crystals. All X-ray diffraction data sets were collected at 100 K at beamline I03 of the Diamond synchrotron. Single wavelength datasets were collected for all crystals as detailed in Table 2 . To determine the identity of the binding metal, an EXAFS scan was performed using station I03. An energy of 20 keV was used for the EXAFS scan. Data for crystal 1 were processed using MOSFLM version 7.0.2 31 and SCALA; 32 data for crystals 2 and 3 were processed using iMOSFLM version 1.0.3 and SCALA. Initial phases for crystal 1 were determined by molecular replacement using the structure of one monomer from C. jejuni GmhA (PDB ID: 1TK9) as a model. Molecular replacement was performed using PHASER. 33 Eight protomers were observed in the asymmetric unit. Single wavelength anomalous data were collected for crystal 3: using SHELX C/D/E 34 and the HKL2MAP pipeline, 35 precisely four zinc atom sites were located. Phasing statistics were calculated using SHARP. 36 An initial structure was determined using ARP/wARP version 7.0. 37 Model building and refinement of the structures was performed using Coot version 0.5.2 38 and PHENIX version 1.5-2. 39 TLS groups were generated using TLSMD. 40 Structures were validated using PHENIX, Coot and MOLPROBITY. 41 Structural images were prepared using the PyMOL molecular graphics system (DeLano Scientific).
Sedoheptulose 7-Phosphate (S7P) Synthesis
S7P for enzyme assays was purchased from Carbosynth. For crystallization, S7P was synthesized using an irreversible activity of transketolase. E. coli transketolase was the gift of J. Littlechild, Exeter. Purified transketolase was incubated at 0.15 mg/mL in 50 mM Hepes pH 7.5, 1 mM EDTA pH 8.0, 6 mM 2-mercaptoethanol, 2 mM thiamine pyrophosphate, 7.5 mM CaCl 2 for 20 min at room temperature. One volume each of 40 mM ribose-5-phosphate and 80 mM -hydroxypyruvate were added to four volumes of this mixture, and incubated at 37°C overnight. The mixture was then incubated at 70°C for 10 min to eliminate the enzyme activity. Greater than 95 % conversion of ribose-5-phosphate to sedoheptulose 7-phosphate was confirmed by HPLC.
GmhA Enzyme Activity Assay
GmhA activity was monitored by coupling product formation to WcbL and WcbN and monitoring P i release, in an analogous manner to the methods of DeLeon et al. 42 Briefly, a reaction mixture was formed consisting of 20 mM HEPES, pH 8.0, 10 mM MgCl 2 , 10 mM KCl, 200 M ATP, 9 g/mL WcbL, 34 g/mL WcbN, and 36-90 g/mL GmhA (final concentrations) in a total volume of 50 L. Reactions were initiated with 50 L of S7P for final concentrations ranging from 0 to 1.5 mM. Samples were incubated at 37°C for 10 min, and the reaction was terminated by heating to 70°C for 5 minutes. The phosphate concentration was determined by the addition of 25 L of 5.6 % (w/v) ammonium molybdate, 0.006 % (w/v) malachite green in 6 M HCl to 90 L of reaction product. The absorbance at 660 nm was then determined using a Spectra MR plate reader (Dynex). The rate of GmhA was determined by comparison to a phosphate standard curve ranging from 0-200 M phosphate, and to negative controls containing no
GmhA. All reactions were performed in triplicate, and a total of eight substrate concentrations were tested for each sample. The kinetic parameters of each GmhA preparation were determined by fitting the data to the Michaelis-Menten equation, using SPSS version 16 (SPSS Inc.). Activity figures are given per GmhA holoenzyme. A detection limit of 0.006 s -1 was determined for this assay.
Accession numbers
The co-ordinates and structure factors for the structures described in this paper have been submitted to the Protein Data Bank with accession numbers 2X3Y and 2XBL for crystals 1 and 2 respectively.
Experimental data for crystal 3 have been submitted with the structure for crystal 2. implicated H180 (numbering is given for E. coli ortholog for residues marked *; equivalent B. pseudomallei residues are E68 and H183 respectively) as the catalytic acid for the isomerization of S7P. (b) Mechanism proposed by this work shows Q175 as a catalytic acid. In the middle step, Q175 forms an imine, stabilized by the presence of zinc. (c) Proposed mechanism for the cyclization to form M7P. D98 is proposed to act as both acid and base, with a protonated form stabilized by a hydrogen bond to S71. The preference for the -anomer appears to be driven by a hydrogen bond between the carbonyl oxygen and the main chain of R72 in the linear form (see Figure 9 ). Figure 9 : Proposed mechanism for sugar cyclization to form M7P. A representative active site of crystal 2 is shown. Key side chains and ligand are shown as sticks, with the protein chains colored yellow, pink and cyan, and the ligand white. D98 is poised to act as a proton donor/acceptor for M7P O1 and O5 respectively (dashed orange lines), with S71 making a hydrogen bond (dashed pink line) to stabilize the protonated form of D98. In the linear form of the sugar, O1 would make a hydrogen bond (dashed blue line) with the main chain amide of R72, driving the cyclized sugar to the -anomer.
